Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS Technologies

We estimate that 208,000 deep brain stimulation (DBS) devices have been implanted to address neurological and neuropsychiatric disorders worldwide. DBS Think Tank presenters pooled data and determined that DBS expanded in its scope and has been applied to multiple brain disorders in an effort to modulate neural circuitry. The DBS Think Tank was founded in 2012 providing a space where clinicians, engineers, researchers from industry and academia discuss current and emerging DBS technologies and logistical and ethical issues facing the field. The emphasis is on cutting edge research and collaboration aimed to advance the DBS field. The Eighth Annual DBS Think Tank was held virtually on September 1 and 2, 2020 (Zoom Video Communications) due to restrictions related to the COVID-19 pandemic. The meeting focused on advances in: (1) optogenetics as a tool for comprehending neurobiology of diseases and on optogenetically-inspired DBS, (2) cutting edge of emerging DBS technologies, (3) ethical issues affecting DBS research and access to care, (4) neuromodulatory approaches for depression, (5) advancing novel hardware, software and imaging methodologies, (6) use of neurophysiological signals in adaptive neurostimulation, and (7) use of more advanced technologies to improve DBS clinical outcomes. There were 178 attendees who participated in a DBS Think Tank survey, which revealed the expansion of DBS into several indications such as obesity, post-traumatic stress disorder, addiction and Alzheimer's disease. This proceedings summarizes the advances discussed at the Eighth Annual DBS Think Tank.

Citing Articles

Neurosurgery for mental conditions and pain: An historical perspective on the limits of biological determinism.

Coffey R, Caroff S Surg Neurol Int. 2025; 15():479.

PMID: 39777168 PMC: 11705162. DOI: 10.25259/SNI_819_2024.

Deep brain stimulation for the treatment of substance use disorders: a promising approach requiring caution.

Sakai J, Tanabe J, Battula S, Zipperly M, Mikulich-Gilbertson S, Kern D Front Psychiatry. 2024; 15:1435109.

PMID: 39071229 PMC: 11272460. DOI: 10.3389/fpsyt.2024.1435109.

FaceMotionPreserve: a generative approach for facial de-identification and medical information preservation.

Zhu B, Zhang C, Sui Y, Li L Sci Rep. 2024; 14(1):17275.

PMID: 39068186 PMC: 11283491. DOI: 10.1038/s41598-024-67989-5.

Case report: First experience with stimulating anterior thalamic nuclei in pharmacoresistant epilepsy in Kazakhstan.

Abzalova V, Kauynbekova S, Makhambaev G, Dmitriev A, Tuleubaev B Front Hum Neurosci. 2024; 18:1417382.

PMID: 39050381 PMC: 11267246. DOI: 10.3389/fnhum.2024.1417382.

Optogenetic behavioral studies in depression research: A systematic review.

Spreen A, Alkhoury D, Walter H, Muller S iScience. 2024; 27(5):109776.

PMID: 38726370 PMC: 11079475. DOI: 10.1016/j.isci.2024.109776.

References

Giordano J . Commentary: The Value of Patient Benefit: Consideration of Framing Contingencies to Guide the Ethical Use of DBS-a Case Analysis. Camb Q Healthc Ethics. 2016; 25(4):755-8. DOI: 10.1017/S0963180116000530. View

Reich M, Horn A, Lange F, Roothans J, Paschen S, Runge J . Probabilistic mapping of the antidystonic effect of pallidal neurostimulation: a multicentre imaging study. Brain. 2019; 142(5):1386-1398. DOI: 10.1093/brain/awz046. View

Holmes A, Hollinshead M, OKeefe T, Petrov V, Fariello G, Wald L . Brain Genomics Superstruct Project initial data release with structural, functional, and behavioral measures. Sci Data. 2015; 2:150031. PMC: 4493828. DOI: 10.1038/sdata.2015.31. View

Chen Y, Gong C, Tian Y, Orlov N, Zhang J, Guo Y . Neuromodulation effects of deep brain stimulation on beta rhythm: A longitudinal local field potential study. Brain Stimul. 2020; 13(6):1784-1792. DOI: 10.1016/j.brs.2020.09.027. View

Wu H, Adler S, Azagury D, Bohon C, Safer D, Barbosa D . Brain-Responsive Neurostimulation for Loss of Control Eating: Early Feasibility Study. Neurosurgery. 2020; 87(6):1277-1288. PMC: 8599841. DOI: 10.1093/neuros/nyaa300. View

Topalovic U, M Aghajan Z, Villaroman D, Hiller S, Christov-Moore L, Wishard T . Wireless Programmable Recording and Stimulation of Deep Brain Activity in Freely Moving Humans. Neuron. 2020; 108(2):322-334.e9. PMC: 7785319. DOI: 10.1016/j.neuron.2020.08.021. View

Cassar I, Titus N, Grill W . An improved genetic algorithm for designing optimal temporal patterns of neural stimulation. J Neural Eng. 2017; 14(6):066013. PMC: 5730972. DOI: 10.1088/1741-2552/aa8270. View

Shirvalkar P, Veuthey T, Dawes H, Chang E . Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain. Front Comput Neurosci. 2018; 12:18. PMC: 5879131. DOI: 10.3389/fncom.2018.00018. View

Riva-Posse P, Choi K, Holtzheimer P, McIntyre C, Gross R, Chaturvedi A . Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression. Biol Psychiatry. 2014; 76(12):963-9. PMC: 4487804. DOI: 10.1016/j.biopsych.2014.03.029. View

10.

Jia F, Wagle Shukla A, Hu W, Almeida L, Holanda V, Zhang J . Deep Brain Stimulation at Variable Frequency to Improve Motor Outcomes in Parkinson's Disease. Mov Disord Clin Pract. 2019; 5(5):538-541. PMC: 6207106. DOI: 10.1002/mdc3.12658. View

11.

Neumann W, Staub-Bartelt F, Horn A, Schanda J, Schneider G, Brown P . Long term correlation of subthalamic beta band activity with motor impairment in patients with Parkinson's disease. Clin Neurophysiol. 2017; 128(11):2286-2291. PMC: 5779610. DOI: 10.1016/j.clinph.2017.08.028. View

12.

Deisseroth K, Hegemann P . The form and function of channelrhodopsin. Science. 2017; 357(6356). PMC: 5723383. DOI: 10.1126/science.aan5544. View

13.

Lofredi R, Tan H, Neumann W, Yeh C, Schneider G, Kuhn A . Beta bursts during continuous movements accompany the velocity decrement in Parkinson's disease patients. Neurobiol Dis. 2019; 127:462-471. PMC: 6520224. DOI: 10.1016/j.nbd.2019.03.013. View

14.

Grado L, Johnson M, Netoff T . Bayesian adaptive dual control of deep brain stimulation in a computational model of Parkinson's disease. PLoS Comput Biol. 2018; 14(12):e1006606. PMC: 6298687. DOI: 10.1371/journal.pcbi.1006606. View

15.

Pena E, Zhang S, Patriat R, Aman J, Vitek J, Harel N . Multi-objective particle swarm optimization for postoperative deep brain stimulation targeting of subthalamic nucleus pathways. J Neural Eng. 2018; 15(6):066020. PMC: 6424118. DOI: 10.1088/1741-2552/aae12f. View

16.

Riva-Posse P, Crowell A, Wright K, Waters A, Choi K, Garlow S . Rapid Antidepressant Effects of Deep Brain Stimulation and Their Relation to Surgical Protocol. Biol Psychiatry. 2020; 88(8):e37-e39. PMC: 9826729. DOI: 10.1016/j.biopsych.2020.03.017. View

17.

Ewert S, Horn A, Finkel F, Li N, Kuhn A, Herrington T . Optimization and comparative evaluation of nonlinear deformation algorithms for atlas-based segmentation of DBS target nuclei. Neuroimage. 2018; 184:586-598. PMC: 6506227. DOI: 10.1016/j.neuroimage.2018.09.061. View

18.

Trager M, Koop M, Velisar A, Blumenfeld Z, Nikolau J, Quinn E . Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease. Neurobiol Dis. 2016; 96:22-30. DOI: 10.1016/j.nbd.2016.08.003. View

19.

Fenno L, Ramakrishnan C, Kim Y, Evans K, Lo M, Vesuna S . Comprehensive Dual- and Triple-Feature Intersectional Single-Vector Delivery of Diverse Functional Payloads to Cells of Behaving Mammals. Neuron. 2020; 107(5):836-853.e11. PMC: 7687746. DOI: 10.1016/j.neuron.2020.06.003. View

20.

Eusebio A, Thevathasan W, Doyle Gaynor L, Pogosyan A, Bye E, Foltynie T . Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients. J Neurol Neurosurg Psychiatry. 2010; 82(5):569-73. PMC: 3072048. DOI: 10.1136/jnnp.2010.217489. View